Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2004
08/19/2004US20040161419 Novel cells obtained from amnion, chorion and decidual layers; expressing markers from Thy-1, OCT-4, SOX2, SSEA3, SSEA4, TRA1-60, TRA1-81, Lefty A, FGF-4, Rex-1 and/or TDGF-1
08/19/2004US20040161414 Method of curing injured spinal cord and therapeutic agents for that
08/19/2004US20040161413 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
08/19/2004US20040161412 Cell-based VEGF delivery
08/19/2004US20040161411 Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system
08/18/2004EP1447443A1 Immortalized mesenchymal cells and utilization thereof
08/18/2004EP1446500A2 A method for regulating immune function in primates using the foxp3 protein
08/18/2004EP1446476A2 Endothelial cells derived from primate embryonic stem cells
08/18/2004EP1446171A1 Augmentation of organ function
08/18/2004EP1446167A2 Treating canker sores with patches to speed healing and relieve pain
08/18/2004EP1446133A2 Methods of improving central nervous system functioning
08/18/2004EP1446015A1 Remodeling of tissues and organs
08/18/2004EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors
08/18/2004EP1060240B1 Lactobacillus strain
08/18/2004EP1045637A4 Decorated red blood cells
08/18/2004EP0866849B1 Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system
08/18/2004EP0835137B1 Encapsulated cells producing viral particles
08/18/2004CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
08/18/2004CN1522113A Capsule containing in vivo cell or tissue
08/18/2004CN1521257A Microencapsulated cell of human tissue kallikrein, microencapsulating method and application thereof
08/18/2004CN1520844A Traditional Chinese medicine composition for cancer
08/18/2004CN1520836A Pharmaceutical composition for treating hepatitis
08/18/2004CN1520829A Earthworm freeze dried powder injection and preparation method
08/18/2004CN1520828A Sleeping recovery healthcare products
08/18/2004CN1162443C Cellular injury response element and uses thereof
08/18/2004CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium
08/18/2004CN1162179C Medicament for curing rhinitis
08/18/2004CN1162175C Chinese medicine composition for curing chloasma
08/18/2004CN1162173C Blood pressure reducing plaster
08/18/2004CN1162172C Traditional Chinese medicine for treating leukemia and concurrently treating aplastic anemia
08/18/2004CN1162171C Gynecopathy treating traditional Chinese medicine
08/18/2004CN1162170C Leukoderma treating medicine and its preparation
08/18/2004CN1162168C Brain nourishing oral liquid and its preparing method
08/18/2004CN1162165C Conception and childbearing helping band
08/18/2004CN1162164C Diabetes treating medicine and its preparation
08/18/2004CN1162161C Staphylococcus aureus metabolin gel and its preparing process
08/18/2004CN1162160C Low agglutinin universal freeze-dried blood plasma
08/17/2004US6777390 Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same
08/17/2004US6777234 Mammalian muscle construct and method for producing same
08/17/2004US6777233 Cell culture of nervous system cells
08/17/2004US6777231 Adipose-derived stem cells and lattices
08/17/2004US6777220 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
08/17/2004US6777203 Telomerase promoter driving expression of therapeutic gene sequences
08/17/2004US6776991 Treating painful penile erection; sexual disorders
08/17/2004US6776985 Encapsulated cells producing viral particles
08/17/2004CA2212010C Extracts of shark cartilage, process of production and uses thereof
08/17/2004CA2133177C Rapamycin formulations for oral administration
08/12/2004WO2004068109A2 Autologous or homologous coagulant produced from anticoagulated whole blood
08/12/2004WO2004067731A1 New strains of bifidobacterium having the ability to produce glutamine
08/12/2004WO2004067729A1 Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
08/12/2004WO2004067704A2 Freeze-dried fibrin matrices and methods for preparation thereof
08/12/2004WO2004067697A2 Icos+ suppresser t cells
08/12/2004WO2004067037A1 Intestinal environment controlling agent for oral use and normal intestinal flora growing kit for oral use
08/12/2004WO2004067013A1 Compositions and methods for restoring bacterial flora
08/12/2004WO2004066969A2 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same
08/12/2004WO2004066965A2 Method of preventing surgical adhesions
08/12/2004WO2004066953A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
08/12/2004WO2004066947A2 Hyperthermia oncolysis co-therapy
08/12/2004WO2004034989A3 Probiotic bacteria
08/12/2004WO2004033665A3 Heterologous plasma cocktail for hiv treatment
08/12/2004WO2003037060A3 Compositions and methods for wt1 specific immunotherapy
08/12/2004WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy
08/12/2004US20040158185 Embolization device
08/12/2004US20040157798 Drug for use in bone grafting
08/12/2004US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix
08/12/2004US20040157323 Biomaterial derived from vertebrate liver tissue
08/12/2004US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
08/12/2004US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor
08/12/2004US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein
08/12/2004US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease
08/12/2004US20040156878 Implantable medical device seeded with mammalian cells and methods of treatment
08/12/2004US20040156871 hydrophilic/hydrophobic solubilizer such as polyoxyethanyl-sitosterol sebacate, polyoxyethanyl-cholesteryl sebacate or polyoxyethanyl- alpha-tocopheryl sebacate with a polyene macrolide antibiotic or a polyunsaturated fatty acid oil
08/12/2004US20040156860 T-cell vaccination for the treatment of multiple sclerosis
08/12/2004US20040156857 particularly glucosamine HCL or glucosamine sulfate with egg from a bird hyperimmunized with an immunogenic or genetic vaccine; reducing or preventing the onset of osteoarthritis and rheumatoid arthritis
08/12/2004US20040156834 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis
08/12/2004US20040156831 The modified holin inactivates the bacterial host prior to production of bacteriophage, so that the bacteriophage infection is non-productive; potential for generation of immune responses against the phage is reduced.
08/12/2004US20040156830 Vector and pharmaceutical composition containing cell death inducing gene
08/12/2004US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
08/12/2004CA2514659A1 New strains of bifidobacterium having the ability to produce glutamine
08/12/2004CA2514474A1 Freeze-dried fibrin matrices and methods for preparation thereof
08/12/2004CA2514001A1 Autologous or homologous coagulant produced from anticoagulated whole blood
08/12/2004CA2513640A1 Method of preventing surgical adhesions
08/12/2004CA2512169A1 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
08/12/2004CA2512161A1 Hyperthermia oncolysis co-therapy
08/11/2004EP1445322A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/11/2004EP1444994A1 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on
08/11/2004EP1444345A1 Conversion of liver stem and progenitor cells to pancreatic functional cells
08/11/2004EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
08/11/2004EP1444330A1 Expansion of t cells in vitro and expanded t cell populations
08/11/2004EP1444329A2 Stem cells that transform to beating cardiomyocytes
08/11/2004EP1444328A2 Induction of beta cell differentiation in human cells
08/11/2004EP1443983A1 Nerve repair unit and method of producing it
08/11/2004EP1443947A1 Use of defibrinated blood for the manufacture of a hemoglobin-based oxygen carrier
08/11/2004EP1443946A2 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
08/11/2004EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
08/11/2004EP1443903A2 Proliposomal drug delivery system
08/11/2004EP1379278A4 Method of inducing proliferation of retinal stem cells
08/11/2004EP1341545A4 Bone putty and method
08/11/2004EP1330253B1 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
08/11/2004EP1272044B1 Protein stabilised emulsions